Thomas W. Griffin
Directeur Technique/Scientifique/R&D chez Janssen Oncology, Inc.
Profil
Thomas W.
Griffin is currently a Vice President-Clinical Research & Development at Janssen Oncology, Inc. He previously worked as an Executive Director-Oncology Therapeutics at Amgen, Inc., an Executive Director-Clinical Discovery at Bristol-Myers Squibb Pharmaceutical Research Institute, a Vice President-Clinical Research & Development at Cougar Biotechnology, Inc., and a Principal at Hoffmann-La Roche, Inc. Griffin holds a doctorate degree from Cornell University.
Postes actifs de Thomas W. Griffin
Sociétés | Poste | Début |
---|---|---|
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Directeur Technique/Scientifique/R&D | 29/07/2009 |
Anciens postes connus de Thomas W. Griffin
Sociétés | Poste | Fin |
---|---|---|
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Directeur Technique/Scientifique/R&D | 13/07/2009 |
Bristol-Myers Squibb Pharmaceutical Research Institute | Directeur Technique/Scientifique/R&D | 01/01/2006 |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
AMGEN INC. | Corporate Officer/Principal | - |
Formation de Thomas W. Griffin
Cornell University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
AMGEN INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Health Technology |
Bristol-Myers Squibb Pharmaceutical Research Institute | |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |